Arm Q1 FY2027 Earnings: Record Revenue, AI Tailwinds, and Why the Stock Still Fell 8%

• Total revenue: $1.289 billion, up 22% year-over-year, a record for any first quarter and above the $1.27 billion consensus .
• Royalty revenue: $715 million, up 22% YoY, also a Q1 record .
• Licensing and other revenue: $574 million, up 23% YoY, another Q1 record .
• Non-GAAP EPS: $0.45, up 29% YoY and beating the $0.40 consensus by $0.05 .
• GAAP net income: $270 million, more than double the $130 million in the prior-year quarter .
• Non-GAAP operating margin: 40%, up from 37% a year ago .
• Q2 FY27 guidance: Revenue of $1.37–$1.43 billion, above the $1.35 billion analyst estimate at the midpoint .

What Drove the Record Revenue

Three major trends converged to produce Arm's record quarter:

AI data center demand. Data center royalties more than doubled year-over-year as hyperscalers (AWS, Google, Microsoft, NVIDIA) expanded Arm-based deployments . Cloud AI was the single biggest growth driver . Data center royalty revenue has now doubled YoY for two consecutive quarters .

Arm AGI CPU pipeline explosion. Demand for Arm's artificial general intelligence CPU exceeded $2 billion in cumulative design pipeline for FY27 and FY28 — double the $1 billion opportunity flagged the prior quarter . The AGI CPU was launched in March 2026.

Armv9 architecture transition. Higher royalty rates from Armv9 chips directly boosted royalty revenue per device, as more customers adopt the newer, more lucrative architecture . Chips based on Armv9 technology now contribute around 25% of Arm's royalty revenue .

Stock Performance: Why a Beat Led to a Selloff

Despite the strong results, ARM stock initially fell about 8% after the earnings release . The culprit wasn't the business — it was the price. ARM had been trading above 100x earnings, making it vulnerable to any hint of a slowdown .

The stock later recovered, trading around $280–$300 in the days after, and by early August was breaking out above $280 again . In aggregate, ARM stock fell roughly 34% during July 2026 before stabilizing .

Analyst Reactions: Mixed Sentiment on Valuation

Analyst reactions were divided — generally positive on fundamentals but cautious on valuation:

• Jefferies: Kept Buy rating and $320 price target .
• JPMorgan: Raised target from $240 to $255 .
• Morgan Stanley: Raised target from $202 to $212 .
• Bank of America (Vivek Arya): Maintained Hold but slashed target from $460 to $260, citing concerns about smartphone sales .
• HSBC: Lowered target to $230 and downgraded, calling the CPU narrative "overdone" .
• Wells Fargo: Cut target from $410 to $350 but kept Overweight .
• RBC Capital: Described Arm's valuation as "controversial" given the high multiple .

Consensus: Of 40 analysts, the average rating is Buy with a 12-month price target of ~$287 .

Role of AI Demand and Armv9 Transition

Arm's strategic position in AI became clearer with this quarter's results. CEO Rene Haas stated that "the transition of AI infrastructure to Arm continued to accelerate" . The Armv9 architecture is a key lever: its higher royalty rates mean that as adoption grows, each chip generates more revenue for Arm. Arm highlighted that rising Armv9 adoption is "lifting royalty revenue per device" .

Arm raised its long-term revenue target to $25 billion, underpinned by AI expansion and Armv9 penetration . However, smartphone weakness and elevated memory prices led Arm to trim its full-year royalty-growth outlook to the "high teens," which tempered some of the enthusiasm .